Dr. Jill S. Waibel, MD

Dr. Waibel practices at Integrated Dermatology of South Miami in Boca Raton, Florida.

Dr. Waibel's NPI, 1154347847, was assigned on July 14, 2006. Dr. Waibel graduated from Boonshoft School of Medicine in 2001. Dr. Waibel holds Florida license ME99968.

Dr. Waibel's primary practice is Integrated Dermatology of South Miami, at 4700 Exchange Ct, Boca Raton, FL 33431 in Palm Beach County. The practice phone is (305) 279-6060.

Dr. Waibel's primary practice is Integrated Dermatology of South Miami in Boca Raton, Florida. Dr. Waibel is also affiliated with Geisinger Medical Center. The medical group on file is Integrated Dermatology. Dmand AI also links Dr. Waibel to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Waibel practices, 5 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Waibel's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Waibel is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Waibel's licenses on file in 2 states: Florida and Ohio.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, corns and calluses, facial skin infection, itchy rashes and psoriasis among the conditions Dr. Waibel treats.

CMS data shows 1,107 Medicare services from Dr. Waibel across 15 procedure codes in 2024, for 316 Medicare patients. Medicare paid $73,552 for them.

CMS counts 316 Medicare patients who saw Dr. Waibel in 2024. The largest group is 65 to 74, with 162 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Waibel's median patient age at 54, with 62% women.

In 2024, Dr. Waibel wrote 618 Medicare Part D claims for 182 patients. 96% of them were for generic drugs. CMS names the drug for 508 of them, across 10 drugs with 11 or more claims each, at $9,970 in total drug cost. In 2023, CMS named 860 claims across 14 drugs.

Dr. Waibel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 171 procedures of skin biopsy by Dr. Waibel, more than 83% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 73 papers to Dr. Waibel, published from 2012 to 2025. 2021 was the busiest year, with 7. The most frequent topics are Laser Therapy, Cicatrix and Lasers, Gas. Dr. Waibel has published most often in J Drugs Dermatol. Dr. Waibel's most frequent co-authors are Michael E. Abrouk, MD, Kenneth Robert Beer, MD and Adam Jared Wulkan, MD.

Dmand AI links Dr. Waibel to 12 clinical trials. Conditions studied include Dermatitis, Atopic, Eczema and Chronic Urticaria. Eli Lilly and Company sponsors the most, 7. Open Payments lists research payments to Dr. Waibel that name 6 trials.

CMS Open Payments shows 693 general payments to Dr. Waibel from 62 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 45% of the total. Eli Lilly and Company paid the most, $35,069. It also lists 18 research payments totaling $101,086 from 2016 to 2022, naming 6 clinical trials.

Dmand AI lists 3 awards for Dr. Waibel.

Dr. Waibel graduated from Boonshoft School of Medicine in 2001. Dr. Waibel is a member of AAD and ASDS.

Dr. Waibel is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.